Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06584318

Exploratory Study of Intermittent Hypoxia Intervention on Colorectal Cancer

Exploratory Study of the Impact of Intermittent Hypoxia Intervention on Patients With Colorectal Cancer

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Capital Medical University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to explore the safety and efficacy of intermittent hypoxia intervention on patients with colorectal cancer.

Detailed description

The hypoxic adaptive response is a form of acquired tolerance that occurs by activating internal cellular protective mechanisms and enhancing immune function.This technology was initially utilized in sports training and high-altitude medicine to enhance strength, endurance, and overall athletic performance, as well as to enhance the body's adaptation to high-altitude hypoxia. This technology was initially utilized in sports training and high-altitude medicine to enhance strength, endurance, and overall athletic performance, as well as to enhance the body's adaptation to high-altitude hypoxia. Intermittent hypoxia (IH) refers to periodic hypoxic-normoxic training performed with brief exposure to hypoxia. Previous studies have found that short-term intermittent hypoxia can increase the sensitivity of hypoxia and reduce the severity of acute hypoxia injury, and alleviate acute hypoxia injury by reducing the inflammatory response caused by hypoxia. Intermittent hypoxia has been shown in our team's work to effectively inhibit colorectal cancer tumor progression in mice by enhancing immune cell function. This study aims to explore the safety and efficacy of IH in patients with colorectal cancer using a non-randomized self-controlled trial.

Conditions

Interventions

TypeNameDescription
OTHERIntermittent hypoxia interventionThe intermittent hypoxia protocol refers to 6 cycles of 10 minutes hypoxia inhaling interval by 5 minutes normoxia, which is performed twice a day (at least 6 hours apart) in 7 days.

Timeline

Start date
2024-03-01
Primary completion
2026-03-30
Completion
2026-04-30
First posted
2024-09-04
Last updated
2025-05-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06584318. Inclusion in this directory is not an endorsement.